Tumor News and Research

RSS

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Glioblastoma multiforme is among the most lethal of cancers and the most stubborn in the face of treatment. Fewer than 20 percent of patients survive more than two years after diagnosis, according to the Central Brain Tumor Registry of the United States.

29 Apr 2021

Involuntary job changes are frequent among breast cancer patients

Breast cancer diagnosis: Around 88 percent of patients survive the dangerous disease in the first five years. Work is important for getting back to normality.

28 Apr 2021

Topical therapy can help safely reduce side effect of cancer treatment

Patients with advanced colorectal cancer may be spared from a toxic side effect caused by a type of targeted therapy used to treat the cancer with the help of another drug normally used to treat melanoma, according to a study led by researchers at the UCLA Jonsson Comprehensive Cancer Center and Memorial Sloan Kettering Cancer Center.

28 Apr 2021

ASPS survey reveals COVID-19's impact and patient demand for plastic surgery

The American Society of Plastic Surgeons (ASPS) - the world's largest plastic surgery organization, representing nearly 8,000 members - today released the 2020 results of the organization's annual procedure survey coupled with national consumer research reflecting trends during the COVID-19 era to help predict what 2021 will bring.

28 Apr 2021

Researchers use natural polymer coatings to improve bone-implant integration

Traffic accidents, tumor resections, and congenital diseases can cause significant trauma, which can lead to large bone deformations and/or bone loss. Although bone has some capacity to regenerate, large bone defects cannot be healed without major medical procedures.

27 Apr 2021

NUS study identifies protein that could be targeted to overcome chemoresistance in cancer

Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cancer cells in the body. It is a systemic treatment where drugs travel throughout the body and destroy cancer cells that have spread (metastasized) to parts of the body far away from the original (primary) tumor.

27 Apr 2021

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Two members of the University of Colorado Cancer Center have received prestigious Idea Awards from the U.S. Department of Defense's Peer Reviewed Cancer Research Program.

27 Apr 2021

Research opens up the possibility of dietary therapy for cancer

A research group at the RIKEN Center for Biosystems Dynamics Research (BDR) has discovered molecular events that determine whether cancer cells live or die. With this knowledge, they found that reduced consumption of a specific protein building block prevents the growth of cells that become cancerous.

27 Apr 2021

Physician-scientist Dr. David Lyden elected into Association of American Physicians

Weill Cornell Medicine physician-scientist Dr. David Lyden, whose research has led to groundbreaking discoveries about how cancer spreads, has been elected into the esteemed Association of American Physicians.

27 Apr 2021

Prolactin hormone acts as a major contributor to breast cancer development, studies find

The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy.

27 Apr 2021

Researchers identify genetic abnormalities that drive invasiveness in head and neck cancer

A multi-institutional team of researchers has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.

26 Apr 2021

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy

Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients.

26 Apr 2021

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they occur.

26 Apr 2021

Using estrogen to target drug-resistant breast cancer in mice

Researchers at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) hope to make estrogen therapy a more accessible treatment option for breast cancer patients who could benefit from it.

26 Apr 2021

Scientists decode activation mechanism of SHP2 protein that can trigger cancer

There are many different types of cancer, but they all have one thing in common: errors in the signals that control normal cell behavior can cause uncontrolled cell growth and cell division, leading to a tumor.

23 Apr 2021

Contralateral esophagus sparing technique can prevent complication in lung cancer patients

For many patients with localized lung cancer (non-small-cell lung carcinoma and small cell lung carcinoma), high-dose radiation with concurrent chemotherapy is a potential cure. Yet this treatment can cause severe, acute inflammation of the esophagus (esophagitis) in about one in five patients, requiring hospitalization and placement of a feeding tube.

23 Apr 2021

New potential target for treating metastasized oral malignant melanoma in dogs

Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.

23 Apr 2021

Cognitive outcomes in survivors of childhood cancers have been largely understudied

In a new study led by Yale Cancer Center, researchers report many survivors of childhood cancers receive systemic therapies associated with cognitive effects and chronic health conditions that may impact long-term cognitive outcomes with downstream effects on education, employment, and income.

23 Apr 2021

New method helps map the specialized diversity and spatial location of cells within a tissue or tumor

Not all cancer cells within a tumor are created equal; nor do all immune cells (or all liver or brain cells) in your body have the same job. Much of their function depends on their location.

23 Apr 2021

Changing the treatment paradigm for ‘cold’ tumors

Not all cancerous tumors are created equal. Some tumors, known as "hot" tumors, show signs of inflammation, which means they are infiltrated with T cells working to fight the cancer. Those tumors are easier to treat, as immunotherapy drugs can then amp up the immune response.

22 Apr 2021

Tumor News and Research

Researchers receive $3.75 million to study the impact of fluid flow on CAR-T cell therapy for brain cancer

Involuntary job changes are frequent among breast cancer patients

Topical therapy can help safely reduce side effect of cancer treatment

ASPS survey reveals COVID-19's impact and patient demand for plastic surgery

Researchers use natural polymer coatings to improve bone-implant integration

NUS study identifies protein that could be targeted to overcome chemoresistance in cancer

CU Cancer Center researchers receive PRCRP grant to investigate metastasis

Research opens up the possibility of dietary therapy for cancer

Physician-scientist Dr. David Lyden elected into Association of American Physicians

Prolactin hormone acts as a major contributor to breast cancer development, studies find

Researchers identify genetic abnormalities that drive invasiveness in head and neck cancer

Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy

Hormonal therapies for breast and prostate cancers increase the risk of heart attack, stroke

Using estrogen to target drug-resistant breast cancer in mice

Scientists decode activation mechanism of SHP2 protein that can trigger cancer

Contralateral esophagus sparing technique can prevent complication in lung cancer patients

New potential target for treating metastasized oral malignant melanoma in dogs

Cognitive outcomes in survivors of childhood cancers have been largely understudied

New method helps map the specialized diversity and spatial location of cells within a tissue or tumor

Changing the treatment paradigm for ‘cold’ tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News